Left atrial appendage closure during open-heart surgery
Part of Heart & circulation clinical trials.
This study looks at a device called ECLIPTIS that closes a small pouch in the heart called the left atrial appendage during open-heart surgery. Closing this pouch may lower the risk of stroke in people having heart surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- Able to give consent and attend follow-up visits
- Scheduled for open-heart surgery and receiving the ECLIPTIS device
- No prior heart surgery
- No emergency surgery
- No blood clot in the heart that can't be removed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if closing the left atrial appendage with a special stitch during planned heart surgery can help prevent strokes in people with atrial fibrillation. If you already need heart surgery, this extra step may reduce your future stroke risk.
This study tests whether closing a heart pocket called the left atrial appendage can lower future stroke or other clot-related events in people with atrial fibrillation. It’s mainly for people who have had a prior clot-related event or are at higher risk but may not be good candidates for long-term blood thinners.
This trial tests whether closing the left atrial appendage (a small sac in the heart) during open-heart surgery can help prevent stroke later on. If you are already scheduled for open-heart surgery, joining this study may add a simple step that could lower your stroke risk.
This study tracks patients who have a minimally invasive procedure to close off a small pouch in the heart called the left atrial appendage. The procedure aims to reduce stroke risk, and this registry collects information about how patients do after the procedure.
This study looks at a part of the heart called the left atrial appendage during open-heart surgery. It aims to learn more about heart rhythm problems and blood clots, which may help improve future treatments.
This trial compares two different devices (Amplatzer Amulet and LAmbre) used to close a small pouch in the heart called the left atrial appendage. People with atrial fibrillation who are at high risk for stroke and bleeding may be able to stop blood thinners after the procedure.
Hear when a new Atrial Appendage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.